Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/39
Publisher
UK
This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- MHRA UK
- Region
- UK
- Scope
- Regulatory
- Published
- September 23, 2026
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on gov.uk
Leave the platform to read the original full article on the publisher site.
Source: MHRA UK
Scope: Regulatory
Related coverage
More related coverage
COVID-19 vaccination: vaccine product information
Information on the presentation, doses and storage of COVID-19 vaccines.
New Safety Module in the Clinical Trials Information System (CTIS)
Williams Cystoscopic Injection Needle
Cook Medical identified that products supplied in the affected device lots may have been manufacture...
OmniaSecure™ MRI SureScan™
The model 3930M is a transvenous DF4 lead labelled for use in the RV and left bundle branch area (LB...